HMPV Cases Rise Globally: Experts Stress No Cause for Alarm

The human metapneumovirus, a common seasonal respiratory virus, sees typical winter surges in multiple countries, with health agencies emphasizing it is not a new or pandemic-level threat.

HMPV, first identified in 2001, is a well-known respiratory virus that typically causes mild cold-like symptoms but can lead to severe illness in vulnerable populations such as infants, the elderly, and immunocompromised individuals.
Countries like China, India, and the UK report seasonal increases in HMPV cases, consistent with expected winter trends for respiratory illnesses, according to the World Health Organization (WHO).
Health authorities in India confirm over 200 cases in 2024, with no unusual spike observed; surveillance systems remain active, and testing facilities are available across the country.
China's CDC and WHO dismiss claims of overwhelmed healthcare systems, emphasizing that current respiratory illness rates, including HMPV, align with normal seasonal patterns.
There is no vaccine for HMPV, but preventive measures like hand hygiene, mask-wearing, and avoiding crowded areas are recommended to reduce transmission, particularly for high-risk groups.